Anthem Biosciences Quarterly Results for Trading Insights
ANTHEM • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹173 Cr
QSept 2025
Anthem Biosciences Quarterly Results Key Highlights
- Revenue of ₹598 Cr in Sept 2025 (+20.3% vs Mar 2025, +8.1% vs Sept 2024)
- Net Profit of ₹173 Cr in Sept 2025 (+108.4% vs Mar 2025, +6.8% vs Sept 2024)
- EBITDA of ₹266 Cr in Sept 2025 (+27.3% vs Mar 2025)
- Operating Margin of 40.0% in Sept 2025 (+0.0pp vs Mar 2025)
- Earnings Per Share of ₹3.09 in Sept 2025 (+108.8% vs Mar 2025)
Anthem Biosciences Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 598 | 497 | 563 | 457 | 553 | 20.3% | 8.1% |
| Net Profit (₹ Cr) | 173 | 83 | 136 | 93 | 162 | - | - |
| EBITDA (₹ Cr) | 266 | 209 | 214 | 165 | 223 | - | - |
| EPS (₹) | 3.09 | 1.48 | 2.43 | 1.65 | 2.90 | - | - |
| Operating Margin (%) | 40.0% | 40.0% | 35.0% | 31.0% | 37.0% | - | - |
Anthem Biosciences Share Price Trend Around Quarterly Results
Visualize Anthem Biosciences's 1-year price movement across quarterly results — ideal for logging trades in Anthem Biosciences share price
chart using Tickjournal. All values in ₹.
Related Pages for Anthem Biosciences
Additional stock information and data for ANTHEM
Revenue Trend (₹ Cr)
Dec 2025
457
Jun 2025
563
Mar 2025
497
Sept 2025
598
Net Profit Trend (₹ Cr)
Dec 2025
93
Jun 2025
136
Mar 2025
83
Sept 2025
173
Operating Margin Trend (%)
Dec 2025
31.0%
Jun 2025
35.0%
Mar 2025
40.0%
Sept 2025
40.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Anthem Biosciences quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹416,764.48 Cr | 1752.5 | 14,875 | 3,125 | +10.8% | - | 21.0% | 134.8 |
|
Divis Laboratories
Sept 2025 |
₹170,125.54 Cr | 6403.5 | 2,860 | 689 | +7.1% | - | 24.1% | 246.6 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹146,658.56 Cr | 4369.2 | 3,219 | 591 | +11.3% | - | 18.4% | 249.1 |
|
Cipla
Sept 2025 |
₹109,178.44 Cr | 1351.6 | 7,716 | 1,353 | +12.0% | - | 17.5% | 80.8 |
|
Dr Reddys Laborator…
Sept 2025 |
₹107,358.50 Cr | 1294.4 | 9,135 | 1,337 | +1.1% | - | 14.6% | 80.0 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores